Pulse Biosciences, Inc. Increase Decrease In Operating Lease Liability
Pulse Biosciences, Inc. (PLSE) reported Increase Decrease In Operating Lease Liability of -$758.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- Pulse Biosciences, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$383.00K.
- Pulse Biosciences, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$375.00K.
- Pulse Biosciences, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$360.00K.
- Pulse Biosciences, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$355.00K.
- Pulse Biosciences, Inc. increase decrease in operating lease liability for fiscal 2025 was -$1.37M.
- Pulse Biosciences, Inc. increase decrease in operating lease liability for fiscal 2024 was -$1.08M.
- Pulse Biosciences, Inc. increase decrease in operating lease liability for fiscal 2023 was -$896.00K.
- Pulse Biosciences, Inc. increase decrease in operating lease liability for fiscal 2022 was -$774.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$383.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$758.00K 10-Q · filed 2026-08-06 | -$1.12M derived: sum of 3 quarters · filed 2026-08-06 | -$1.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$375.00K 10-Q · filed 2026-05-14 | -$735.00K derived: sum of 2 quarters · filed 2026-05-14 | -$1.09M derived: sum of 3 quarters · filed 2026-05-14 | -$1.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$360.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$715.00K derived: sum of 2 quarters · filed 2026-02-19 | -$1.05M derived: sum of 3 quarters · filed 2026-08-06 | -$1.37M 10-K · filed 2026-02-19 |
| 2025-09-30 | -$355.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$687.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.01M 10-Q · filed 2025-11-05 | -$1.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$332.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$653.00K 10-Q · filed 2026-08-06 | -$952.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$321.00K 10-Q · filed 2026-05-14 | -$620.00K derived: sum of 2 quarters · filed 2026-05-14 | -$896.00K derived: sum of 3 quarters · filed 2026-05-14 | -$1.15M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$575.00K derived: sum of 2 quarters · filed 2026-02-19 | -$829.00K derived: sum of 3 quarters · filed 2026-02-19 | -$1.08M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$530.00K derived: sum of 2 quarters · filed 2025-11-05 | -$777.00K 10-Q · filed 2025-11-05 | -$1.02M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$501.00K 10-Q · filed 2025-08-12 | -$741.00K derived: sum of 3 quarters · filed 2025-08-12 | -$976.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$247.00K 10-Q · filed 2025-05-08 | -$487.00K derived: sum of 2 quarters · filed 2025-05-08 | -$722.00K derived: sum of 3 quarters · filed 2025-05-08 | -$936.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$475.00K derived: sum of 2 quarters · filed 2025-03-31 | -$689.00K derived: sum of 3 quarters · filed 2025-03-31 | -$896.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$235.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$449.00K derived: sum of 2 quarters · filed 2024-10-30 | -$656.00K 10-Q · filed 2024-10-30 | -$857.00K derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | -$214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | -$421.00K 10-Q · filed 2024-08-19 | -$622.00K derived: sum of 3 quarters · filed 2024-08-19 | -$826.00K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | -$207.00K 10-Q · filed 2024-05-07 | -$408.00K derived: sum of 2 quarters · filed 2024-05-07 | -$612.00K derived: sum of 3 quarters · filed 2024-05-07 | -$799.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$405.00K derived: sum of 2 quarters · filed 2024-03-28 | -$592.00K derived: sum of 3 quarters · filed 2024-03-28 | -$774.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$391.00K derived: sum of 2 quarters · filed 2023-11-13 | -$573.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$369.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$182.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$542.00K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | -$196.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |